Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Fuji
Deloitte
Healthtrust
Chinese Patent Office
US Army
Cerilliant
Merck
Federal Trade Commission

Generated: February 17, 2019

DrugPatentWatch Database Preview

ARCALYST Drug Profile

« Back to Dashboard

Summary for Tradename: ARCALYST
Patents:19
Applicants:1
BLAs:1
Suppliers: see list1

US Patents for ARCALYST

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Regeneron Pharmaceuticals ARCALYST rilonacept VIAL; SINGLE-USE 125249 001 2008-02-27 ➤ Sign Up The Children\'s Hospital of Philadelphia (Philadelphia, PA) The Trustees of the University of Pennsylvania (Philadelphia, PA) ➤ Sign Up RX Orphan search
Regeneron Pharmaceuticals ARCALYST rilonacept VIAL; SINGLE-USE 125249 001 2008-02-27 ➤ Sign Up Occlugel (Jouy en Josas, FR) Centre National de la Recherche Scientifique (CNRS) (Paris, FR) Assistance Publique Hopitaux de Paris (Paris, FR) Universite Paris Diderot--Paris 7 (Paris, FR) ➤ Sign Up RX Orphan search
Regeneron Pharmaceuticals ARCALYST rilonacept VIAL; SINGLE-USE 125249 001 2008-02-27 ➤ Sign Up Regeneron Pharmaceuticals, Inc. (Tarrytown, NY) ➤ Sign Up RX Orphan company
Regeneron Pharmaceuticals ARCALYST rilonacept VIAL; SINGLE-USE 125249 001 2008-02-27 ➤ Sign Up Regeneron Pharmaceuticals, Inc. (Tarrytown, NY) ➤ Sign Up RX Orphan company
Regeneron Pharmaceuticals ARCALYST rilonacept VIAL; SINGLE-USE 125249 001 2008-02-27 ➤ Sign Up Regeneron Pharmaceuticals, Inc. (Tarrytown, NY) ➤ Sign Up RX Orphan company
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for ARCALYST

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
372 Finland ➤ Sign Up
10C0025 France ➤ Sign Up PRODUCT NAME: RILONACEPT; REGISTRATION NO/DATE IN FRANCE: EU/1/09/582/001 DU 20091023; REGISTRATION NO/DATE AT EEC: EU/1/09/582/001 DU 20091023
CA 2010 00016 Denmark ➤ Sign Up PRODUCT NAME: RILONACEPT
PA2017038 Lithuania ➤ Sign Up PRODUCT NAME: SARILUMABAS; REGISTRATION NO/DATE: EU/1/17/1196 20170623
CR 2017 00061 Denmark ➤ Sign Up PRODUCT NAME: SARILUMAB; REG. NO/DATE: EU/1/17/1196/001-8 20170627
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
McKesson
Express Scripts
US Army
Federal Trade Commission
Accenture
Teva
Deloitte
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.